CytomX Therapeutics (CTMX) Earnings
|
Expand Research on CTMX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +127.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/16/26  |
Q425 | N/A | -$0.09 | N/A | N/A | $9.88M | N/A | N/A | N/A | ||
| 3/4/26 |
Q425 | N/A | -$0.09 | N/A | N/A | $9.88M | N/A | N/A | N/A | ||
| 11/6/25 | Q325 | -$0.09 | -$0.05 | -$0.04 | $5.9M | $11.84M | N/A |  | | Details | |
| 8/7/25 | Q225 | $0.00 | -$0.06 | +$0.06 | $18.7M | $19.1M | N/A | | | Details | |
| 5/12/25 | Q125 | $0.27 | $0.06 | +$0.21 | $50.92M | $29.7M | N/A | | | Details | |
| 3/6/25 |
Q424 | N/A | -$0.21 | N/A | N/A | $12.24M | N/A | N/A | N/A | ||
| 2/26/25 |
Q424 | N/A | -$0.21 | N/A | N/A | $12.24M | N/A | N/A | N/A | ||
| 11/7/24 | Q324 | $0.07 | -$0.17 | +$0.24 | $33.43M | $17.1M | N/A | | | Details |
